These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 31182960)

  • 1. The Combination of Stereotactic Body Radiation Therapy and Immunotherapy in Primary Liver Tumors.
    Kreidieh M; Zeidan YH; Shamseddine A
    J Oncol; 2019; 2019():4304817. PubMed ID: 31182960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.
    Venkat PS; Hoffe SE; Frakes JM
    Cancer Control; 2017; 24(3):1073274817729259. PubMed ID: 28975831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereotactic Body Radiotherapy: Does It Have a Role in Management of Hepatocellular Carcinoma?
    Choi SH; Seong J
    Yonsei Med J; 2018 Oct; 59(8):912-922. PubMed ID: 30187697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereotactic body radiation therapy for primary liver tumors: An effective liver-directed therapy in the toolbox.
    Roberts HJ; Wo JY
    Cancer; 2022 Mar; 128(5):956-965. PubMed ID: 34847255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereotactic body radiotherapy vs. TACE or RFA as a bridge to transplant in patients with hepatocellular carcinoma. An intention-to-treat analysis.
    Sapisochin G; Barry A; Doherty M; Fischer S; Goldaracena N; Rosales R; Russo M; Beecroft R; Ghanekar A; Bhat M; Brierley J; Greig PD; Knox JJ; Dawson LA; Grant DR
    J Hepatol; 2017 Jul; 67(1):92-99. PubMed ID: 28257902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereotactic Body Radiation Therapy (SBRT) Plus Immune Checkpoint Inhibitors (ICI) in Hepatocellular Carcinoma and Cholangiocarcinoma.
    Jiang J; Diaz DA; Nuguru SP; Mittra A; Manne A
    Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereotactic body radiation therapy for hepatocellular carcinoma: From infancy to ongoing maturity.
    Lewis S; Dawson L; Barry A; Stanescu T; Mohamad I; Hosni A
    JHEP Rep; 2022 Aug; 4(8):100498. PubMed ID: 35860434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of external beam radiation therapy in management of hepatocellular carcinoma.
    Sharma H
    J Clin Exp Hepatol; 2014 Aug; 4(Suppl 3):S122-5. PubMed ID: 25755603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase 2 study of stereotactic body radiotherapy and optional transarterial chemoembolization for solitary hepatocellular carcinoma not amenable to resection and radiofrequency ablation.
    Takeda A; Sanuki N; Tsurugai Y; Iwabuchi S; Matsunaga K; Ebinuma H; Imajo K; Aoki Y; Saito H; Kunieda E
    Cancer; 2016 Jul; 122(13):2041-9. PubMed ID: 27062278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current Standard and Future Perspectives in Non-Surgical Therapy for Hepatocellular Carcinoma.
    Eggert T; Greten TF
    Digestion; 2017; 96(1):1-4. PubMed ID: 28605745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term survival analysis in combined transarterial embolization and stereotactic body radiation therapy versus stereotactic body radiation monotherapy for unresectable hepatocellular carcinoma >5 cm.
    Su TS; Lu HZ; Cheng T; Zhou Y; Huang Y; Gao YC; Tang MY; Jiang HY; Lian ZP; Hou EC; Liang P
    BMC Cancer; 2016 Nov; 16(1):834. PubMed ID: 27809890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereotactic Radiotherapy for Hepatocellular Carcinoma, Radiosensitization Strategies and Radiation-Immunotherapy Combination.
    Pérez-Romasanta LA; González-Del Portillo E; Rodríguez-Gutiérrez A; Matías-Pérez Á
    Cancers (Basel); 2021 Jan; 13(2):. PubMed ID: 33430362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined Stereotactic Body Radiotherapy and Checkpoint Inhibition in Unresectable Hepatocellular Carcinoma: A Potential Synergistic Treatment Strategy.
    Chiang CL; Chan ACY; Chiu KWH; Kong FS
    Front Oncol; 2019; 9():1157. PubMed ID: 31799176
    [No Abstract]   [Full Text] [Related]  

  • 14. The Current Role of Stereotactic Body Radiation Therapy (SBRT) in Hepatocellular Carcinoma (HCC).
    Kimura T; Fujiwara T; Kameoka T; Adachi Y; Kariya S
    Cancers (Basel); 2022 Sep; 14(18):. PubMed ID: 36139545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of radiotherapy in the management of hepatocellular carcinoma: A systematic review.
    Kalogeridi MA; Zygogianni A; Kyrgias G; Kouvaris J; Chatziioannou S; Kelekis N; Kouloulias V
    World J Hepatol; 2015 Jan; 7(1):101-12. PubMed ID: 25625001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiotherapy for liver tumors.
    Keane FK; Tanguturi SK; Zhu AX; Dawson LA; Hong TS
    Hepat Oncol; 2015 Apr; 2(2):133-146. PubMed ID: 30190993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereotactic body radiotherapy based treatment for hepatocellular carcinoma with extensive portal vein tumor thrombosis.
    Shui Y; Yu W; Ren X; Guo Y; Xu J; Ma T; Zhang B; Wu J; Li Q; Hu Q; Shen L; Bai X; Liang T; Wei Q
    Radiat Oncol; 2018 Sep; 13(1):188. PubMed ID: 30253783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current Understanding of Ablative Radiation Therapy in Hepatocellular Carcinoma.
    Mathew AS; Dawson LA
    J Hepatocell Carcinoma; 2021; 8():575-586. PubMed ID: 34164350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereotactic Body Radiation Therapy for Liver Tumors: Current Status and Perspectives.
    Doi H; Beppu N; Kitajima K; Kuribayashi K
    Anticancer Res; 2018 Feb; 38(2):591-599. PubMed ID: 29374681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereotactic body radiation therapy in primary hepatocellular carcinoma: current status and future directions.
    Lin TA; Lin JS; Wagner T; Pham N
    J Gastrointest Oncol; 2018 Oct; 9(5):858-870. PubMed ID: 30505586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.